<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0003613'>Antiphospholipid antibodies</z:hpo> (aPL) are an eterogeneous group of immunoglobulins, that include <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> and anticardiolipin antibodies </plain></SENT>
<SENT sid="1" pm="."><plain>Patients with aPL are at high risk of venous and <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo>, <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> and recurrent fetal loss </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0003613'>Antiphospholipid antibodies</z:hpo> should be suspected in case of unexplained <z:hpo ids='HP_0100724'>thrombophilia</z:hpo> and prolongation of coagulation assays (aPTT); infact although such antibodies present an <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> effect in vitro, in vivo the interfere with physiological <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> reactions and may have a procoagulant effect </plain></SENT>
<SENT sid="3" pm="."><plain>This paper deals with a case report characterized by a poor sintomatology, a short <z:mp ids='MP_0001914'>bleeding</z:mp>, but a spread of abnormal laboratoristic findings that give us the opportunity to investigate an uncommon syndrome </plain></SENT>
</text></document>